Walleye Trading LLC Insmed Inc Call Options Transaction History

Walleye Trading LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$22.0 - $69.71 $6,600 - $20,912	-300 Reduced 7.5%	3,700 $247,000
Q1 2024 May 15, 2024	SELL	$25.72 - $29.94 $5,144 - $5,988	-200 Reduced 4.76%	4,000 $108,000
Q4 2023 Feb 14, 2024	BUY	$23.42 - $31.74 $98,364 - $133,308	4,200 New	4,200 $130,000
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $86,178 - $115,169	5,300 New	5,300 $90,000
Q2 2021 Aug 16, 2021	SELL	$24.17 - $36.01 $149,854 - $223,262	-6,200 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$32.28 - $44.3 $200,136 - $274,660	6,200 New	6,200 $211,000
Q3 2020 Nov 16, 2020	SELL	$26.0 - $34.5 $1.05 Million - $1.39 Million	-40,400 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$14.11 - $29.42 $510,782 - $1.07 Million	36,200 Added 861.9%	40,400 $1.11 Million
Q1 2020 May 15, 2020	BUY	$13.63 - $33.98 $57,246 - $142,716	4,200 New	4,200 $67,000
Q3 2019 Nov 14, 2019	SELL	$15.49 - $25.78 $455,406 - $757,932	-29,400 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$23.0 - $32.19 $522,100 - $730,713	22,700 Added 338.81%	29,400 $753,000
Q1 2019 May 15, 2019	BUY	$13.91 - $31.15 $93,197 - $208,705	6,700 New	6,700 $195,000

447

170M

5.79M

5.18M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.82B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.